Lactococcus species used as dairy starter cultures are often protected from bacteriophage infection by one or more phage defense mechanisms whose genetic determinants are carried on plasmids. Phage defense mechanisms of particular interest are the abortive phage infection (Abi) mechanisms, because they are effective against a variety of phages (31) . Abi mechanisms are described as those which inhibit phage proliferation at some point after phage adsorption, DNA entry, and early phage gene expression occur (18) . As a consequence of aborted phage infection, the cell dies, but the release of progeny phage is minimized or eliminated.
Significant effort has revealed little about the specific mechanisms by which Abi mechanisms halt phage infection or program cell death. The most detailed studies of abortive infection at the molecular level have been with Escherichia coli. Three mechanisms target the translational machinery of the cell upon phage infection. Bacteriophage T4 is inhibited in cells containing the lit gene encoded by the defective prophage e14 (30) . The lit gene product and the T4 gene 23 product cooperate to cleave EF-Tu, preventing translation of late T4 genes (60) . Inhibition of T4 by Prr occurs via cleavage of the host tRNA Lys (3, 32) . Phage is excluded from E. coli rap mutants by interference with peptidyl-tRNA hydrolase activity (40) . Several other E. coli abortive infections have been studied. A model for the mechanism of exclusion of T4 rII mutants by rex lysogens was proposed by Parma et al. (47) . They proposed that upon T4 infection, RexA activates the RexB protein to insert into the cell membrane, forming an ion channel through which membrane potential is lost. Phage T7 is inhibited by the PifA protein encoded by the F plasmid (13) . The products of two T7 genes, 1.2 and 10, are directly involved in abortion of the T7 infection, although their exact roles have not been determined (38) .
Although the genes encoding eight Abi mechanisms in Lactococcus species have been cloned and sequenced (4, 11, 12, 19, 21, 25, 35, 41) , the specific mechanisms by which they inhibit phages are poorly understood. Recent studies have begun to reveal the molecular basis for inhibition by some of the lactococcal Abi mechanisms. Parreira et al. (48) reported that AbiB promotes dramatic degradation of sensitive phage transcripts early in the infection cycle. They proposed that an early phage product induces the synthesis or stimulates activity of an RNase in cells carrying AbiB. Numerous phage mutants that are insensitive to Abi mechanisms have been described previously (5, 16, 19, 24, 37, 49, 58) and can be used as tools to study the modes of action of these defense systems. This approach was taken by Bidnenko et al. (5) in the study of the AbiD1 abortive infection mechanism. A cloned DNA fragment from an AbiD1-insensitive phage partially complemented growth of an AbiD1-sensitive phage in the presence of AbiD1. Sequence analysis of the cloned phage fragment revealed an operon comprised of four open reading frames (ORFs). orf3 is required for the complementation phenotype, but mutations in AbiD1-insensitive phages were localized by marker rescue to orf1. Because overexpression of orf3 can overcome the AbiD1 phenotype against the sensitive phage, Bidnenko et al. (5) suggested that AbiD1 acts to decrease the amount of the orf3 product. RNA analysis indicated that the proposed decrease in the orf3 product is not the result of repressed transcription of the operon in AbiD1 cells.
The focus of the present study was the AbiA phage resistance mechanism which is effective against phages of four species and three morphotypes (26, 27, 29) . The abiA gene was cloned independently from two lactococcal plasmids, pTR2030 (27) and pCI829 (12) , and was sequenced (12, 25) . Hill et al. (24) demonstrated that phage 31 DNA replication does not occur in cells containing the AbiA mechanism; however, the specific interaction between AbiA and the phage remains unknown. To investigate the mode of action of AbiA, we have isolated and characterized spontaneous phage 31 mutants that are insensitive to AbiA. The study of these phage 31 derivatives led to the identification and characterization of a region in the phage 31 genome that is involved in its sensitivity to the AbiA phage resistance mechanism.
MATERIALS AND METHODS
Bacterial strains, bacteriophages, and plasmids. The bacterial strains, bacteriophages, and plasmids used in this study are listed in Table 1 . Lactococcus lactis cultures were propagated at 30°C in M17 broth (57) supplemented with 0.5% (wt/vol) glucose (GM17). Erythromycin (1.5 g/ml) and/or chloramphenicol (7.5 g/ml) were added to the broth when appropriate. Bacteriophages were propagated and titrated as previously described (57) . E. coli strains used for plasmid isolation and cloning were propagated at 37°C in LB medium (52) . Plasmids were maintained in E. coli by the addition of erythromycin (100 g/ml) or chloramphenicol (7.5 g/ml) to the growth medium.
DNA isolation, cloning, and transformation. Rapid plasmid isolations from E. coli were performed by alkaline lysis (52) . Plasmid DNA was isolated from L. lactis strains by the method of O'Sullivan and Klaenhammer (44) . Phage DNA was isolated using the method of Raya et al. (51) . General procedures for DNA manipulations were performed as previously described (52) . DNA was purified from agarose gels with the GeneCleanII (Bio 101, La Jolla, Calif.) or the Qiaex II Gel Extraction kit (Chatsworth, Calif.). Restriction endonucleases, T4 DNA ligase, and their corresponding buffers were purchased from Boehringer Mannheim Biochemicals (Indianapolis, Ind.).
L. lactis strains were prepared for electroporation by the method of Holo and Nes (28) , except that sucrose was omitted from the growth and resuspension media. Transformants were selected on GM17 agar plates containing erythromycin (1.5 g/ml) and/or chloramphenicol (7.5 g/ml). RbCl-competent E. coli cells were prepared by the procedure of Hanahan (23) with the following modifications by Robert Hallewell (Chiron Corporation). A 100-ml volume of cells in mid-log phase was centrifuged and resuspended in 30 ml of transformation buffer I (30 mM potassium acetate, 50 mM MnCl 2 , 100 mM RbCl, 10 mM CaCl 2 , and 15% [wt/vol] glycerol; pH 5.8). The cells were incubated on ice in transformation buffer I for 2 hours and then centrifuged and resuspended in 4 ml of transformation buffer II (10 mM sodium MOPS [pH 7.0], 75 mM CaCl 2 , 10 mM RbCl, 15% glycerol). The cells were frozen at Ϫ70°C in 100-l aliquots and transformed by the procedure described for CaCl 2 -competent cells (52) . Transformants were selected on brain heart infusion agar plates containing erythromycin (100 g/ml) or LB agar plates containing chloramphenicol (7.5 g/ml) or ampicillin (100 g/ml).
Heteroduplex analysis. Analysis of 31::31A DNA hybrids for heteroduplexes was performed with the mutation detection enhancement (MDE) gel matrix (AT Biochem, Malvern, Pa.). Preparation of DNA hybrids for electrophoresis through the MDE gel was as follows. Cloned phage DNA fragments were isolated from plasmids pTRK402 and pTRK403 cut with EcoRV and SalI or from plasmids pTRK361 and pTRK401 cut with SalI and BamHI. The phage DNA fragments, which were designated 31(EcoRV-SalI), 31A(EcoRV-SalI), 31(SalI-BamHI), and 31A(SalI-BamHI), were purified from agarose gels and digested with ApoI, TaqI, or DraI-RsaI to generate smaller fragments within the range recommended to allow detection of heteroduplexes (200 to 900 bp). Three enzyme digests were analyzed to increase the probability that the entire EcoRVSalI or SalI-BamHI fragment was represented in the appropriate fragment length for detection of heteroduplexes.
Each digest of 31 DNA was then combined 1:1 with the comparable 31A DNA digest (1 g of each). For example, TaqI-digested 31(EcoRV-SalI) was combined with TaqI-digested 31A(EcoRV-SalI). Negative controls containing 2 g of DNA from each phage individually were also prepared. All samples were in their respective restriction enzyme buffers at a final volume of 10 to 25 l, depending on the DNA concentration. EDTA was added to a final concentration of 50 mM. The combined DNA samples were denatured by boiling for 5 min and then were cooled slowly to 37°C to allow the DNA strands to anneal. The sample buffer supplied with the MDE gel was added to the annealed samples (1 l of buffer per 5-l sample). A 1.0ϫ MDE gel (31 cm by 38.5 cm by 1 mm) containing urea was prepared as described by the manufacturer. Samples were electrophoresed in 0.6ϫ Trisborate-EDTA at 800 V for 16 to 24 h. Optimum heteroduplex detection occurred when the fragment migrated at least 30 cm through the gel matrix. Therefore, electrophoresis times varied, depending on the lengths of the fragments being examined. When electrophoresis was completed, DNA bands were detected by silver staining (7), and the gel was dried under vacuum between two pieces of cellulose film (Promega, Madison, Wis.).
DNA sequencing. Cloned phage DNA fragments were used as templates for sequencing by the dideoxy chain termination method (54) with the Sequenase 2.0 kit (Amersham Life Science, Arlington Heights, Ill.). Intact phage genomic DNA was sequenced with the fmol PCR DNA Sequencing system (Promega). DNA sequence assembly and analysis were performed with PC/Gene software (Intelligenetics, Mountain View, Calif.). The BLAST program (2) was used to search for protein and nucleic acid sequence similarities.
PCR and deletion analysis. Taq polymerase (Boehringer Mannheim Biochemicals) or Pfu polymerase (Stratagene, La Jolla, Calif.) was used in PCRs. Thirty cycles of the following steps were used: a 30-s denaturation step at 94°C, a 30-s annealing step at 55°C, and a 1-min extension step at 72°C. The oligonucleotides used in PCRs are described below in Results and in the legend to Fig.  6B .
Deletion analysis of the 31 EcoRV-HindIII fragment was performed according to the protocol of Zhu and Clark (61) . Mung bean nuclease and exonuclease III were purchased from Stratagene and Promega, respectively. Deletions were constructed in pBlueScript KS ϩ (Stratagene) and then subcloned into pTRKH2 for analysis in L. lactis NCK203.
RNA isolations and hybridizations. RNA was isolated from L. lactis strains with the TRIzol reagent (GIBCO-BRL, Gaithersburg, Md.). Approximately 10 8 CFU were resuspended in 1 ml of TRIzol reagent. Glass beads (Ͻ106 m, 0.5 g) were added, and the cells were homogenized for 90 s in a Bead Beater (Biospec Products, Bartlesville, Okla.). The remainder of the RNA isolation procedure was as described by GIBCO-BRL. For RNA isolation during phage infection, each cell pellet was frozen in an ethanol-dry ice bath at each time point. RNA was isolated after all samples were collected. RNA concentrations were determined spectrophotometrically. Samples (8 g) were denatured and applied to a Zeta-probe membrane (Bio-Rad Laboratories, Richmond, Calif.) with a slot blot apparatus (Bio-Dot-SF; Bio-Rad Laboratories) as described by the manufacturer. The RNA was UV cross-linked to the membrane and then hybridized to a 32 P-labeled probe at 65°C as recommended by Bio-Rad. 32 P-labeled probes were prepared with a multiprime DNA labeling kit (Amersham Life Science). The ORF245-specific probe was generated by PCR and corresponds to nucleotides 1186 to 1661 of the sequence shown in Fig. 3 .
RESULTS
Isolation of AbiA-insensitive phage 31 derivatives. Phage 31 infection of L. lactis NCK203 containing pTRK376 (a high-copy-number AbiA plasmid) results in small (0.6-mm) and large (1.2-mm) plaques at a decreased efficiency of plaquing (Table 2) (16) . Phages isolated from these plaques retained insensitivity to pTRK376 after propagation through L. lactis NCK203, indicating that a mutation had occurred in the genomes of these phages. Restriction enzyme fragmentation patterns of DNA isolated from most of the insensitive phages were identical to that of 31. AbiA insensitivity in these phages, therefore, resulted from a substitution, small deletion, or insertion in the phage DNA sequence. Two of these phages, designated 31A and 31B, were chosen for study. 31A was isolated from a large plaque, and 31B was isolated from a small plaque. Although both phages were completely insensitive to inhibition by pTRK376 (pTRKH2::abiA), only 31A was completely insensitive to pTRK406 (pNZ18::abiA) ( Table  2 ). 31B is partially insensitive to pTRK406 with an efficiency of plaquing (EOP) of 8.0 ϫ 10 Ϫ2 (Table 2) . A different type of AbiA-insensitive phage (31.3) was also identified at low frequency upon infection of NCK203 (pTRK376) with 31 (16). In 31.3, an 8-to 9-kb region of the 31 genome was replaced by a region of similar size originating from the L. lactis NCK203 chromosome (Fig. 1A) . Several other independently isolated 31 derivatives with rearrangements in the same region of the 31 genome are also insensitive to AbiA (19a, 42) . The concurrence of AbiA insensitivity and replacement of an 8-to 9-kb region of the 31 genome suggested that the phage determinant(s) affected by AbiA lies within this region. To identify the specific 31 determinant affected by AbiA, the location of the minor mutation responsible for AbiA insensitivity in 31A was investigated.
Localization of a mutation in the 31A genome by heteroduplex analysis. Heteroduplex analysis was used to search for mutations in 31A within the 8-to 9-kb region described above. Any 31A fragment containing a mutation would form a heteroduplex with the corresponding fragment from the wildtype 31. Localization of the mutation was accomplished by electrophoresis of 31::31A DNA strand hybrids through the MDE gel matrix in which homoduplexes and heteroduplexes migrate differently. The 9-kb regions of 31 and 31A were cloned as EcoRVSalI (4.3-kb) and SalI-BamHI (4.5-kb) fragments ( Fig. 1A ; Table 1 ). As described in Materials and Methods, the phage DNA fragments were then purified from the plasmids pTRK361, pTRK401, pTRK402, and pTRK403 and digested with ApoI, DraI plus RsaI, or TaqI. These enzymes generated more 200-to 900-bp fragments than other enzymes screened. A DNA sample from 31 digested with a particular enzyme was combined with the corresponding digested DNA sample from 31A. The combined samples were denatured and reannealed to allow heteroduplex formation.
Analysis of the digested DNA samples from the SalI-BamHI fragment after electrophoresis through the MDE gel did not reveal any heteroduplex bands migrating in a manner different from that of the homoduplex controls (data not shown). Conversely, analysis of the EcoRV-SalI fragments revealed a 425-bp TaqI fragment migrating more slowly than the controls (Fig. 2) . Aberrant migration of the 605-bp DraI/RsaI fragment was also faintly visible. No heteroduplex bands were apparent in the ApoI-digested DNA samples.
DNA sequencing of the 425-bp TaqI fragment and the upstream and downstream regions from 31 and 31A. The 425-bp TaqI fragments from 31 and 31A were cloned separately into the ClaI site of pBlueScript KS ϩ (Stratagene). The DNA sequences of both fragments were determined with the T3 and T7 primers. Comparison of the two DNA sequences revealed a mutation from a G in 31 to a T in 31A (nucleotide 1385 in Fig. 3) . PCR sequencing directly from the 31 and 31A genomes confirmed that this mutation was not an artifact of cloning. Further sequencing of the cloned EcoRVSalI fragment from each phage revealed that this mutation lies within a 738-bp ORF (ORF245) that encodes a putative 245-amino-acid (27.9-kDa) protein. The G-to-T mutation results in a change from an arginine to a leucine in the deduced amino acid sequence (Fig. 3) . A putative ribosomal binding site is located upstream of ORF245.
Extension of the sequence upstream of ORF245 revealed a 510-bp ORF (ORF169) encoding a putative 169-amino-acid protein (19.9 kDa). The proximity of this ORF to ORF245 suggested a relationship in their transcription and possibly in their function (Fig. 3) . A third ORF (ORF71) ends 84 bp upstream of the beginning of ORF169. Within the 84-bp intervening region lie two sets of inverted repeats (Fig. 3) . A total of 1,732 bp was sequenced on both strands from the cloned EcoRV-SalI fragment of each phage (31 and 31A). The only difference between the 31 and 31A sequences was the G-to-T transversion detected by heteroduplex analysis. Hybridization and restriction enzyme analyses defined the location and orientation of the sequenced region within the EcoRV-SalI fragment (Fig. 1B) .
Sequencing of 31B, a 31 derivative with partial resistance to AbiA. The sequence of a partially AbiA-resistant 31 derivative, designated 31B (Table 2) , was determined on one strand throughout the 1,732-bp region sequenced from 31 and 31A. The EcoRV-SalI fragment from this phage was cloned (plasmid pTRK425) and used for sequencing. Phage 31B had a G-to-A substitution in the 84-bp region between the end of ORF71 and the beginning of ORF169 (nucleotide 372 in Fig. 3 ). This part of the 31B genome was sequenced directly by PCR sequencing to confirm that the mutation did not occur during cloning. The importance of the 84-bp region between ORF71 and ORF169 relative to AbiA is discussed below.
The phage 31 sequence has sequence similarity to the lactococcal phage BK5-T. The translated amino acid sequences of ORF71, ORF169, and ORF245 from 31 were compared to the sequences in the PDB, SWISS-PROT, PIR, and GenPept databases (August 1996 releases) with the BLASTP program (2). The search revealed that two ORFs from the genome of a temperate lactococcal phage, BK5-T, have extensive amino acid sequence similarity to ORF169 and ORF245. The search did not indicate similarity between BK5-T and the ORF71 amino acid sequence. Approximately half of the BK5-T genome has recently been sequenced (6 [GenBank accession no. L44593]). ORF169 is 98% identical to the ORF169 from BK5-T, and ORF245 has three regions of similarity (62, 64, and 66% similarity) with ORF234 from BK5-T (Fig. 1C) . ORF169 lies immediately upstream of ORF234 in BK5-T, which is identical to the arrangement of ORF169 and ORF245 in 31. The functions of these BK5-T proteins are unknown.
The entire nucleotide sequence (1,732 bp) was compared to sequences in the PDB, GenBank, and EMBL databases (August 1996 releases) with the BLASTN program (2). BK5-T had the only sequences with significant similarity to this region of 
31.
A region of 757 bp was 84% identical in 31 and BK5-T (Fig. 1C) . The 31 region with DNA sequence similarity to BK5-T begins at nucleotide 338 of the sequence shown in Fig.  3 (75 bp upstream of the beginning of ORF169) and ends at nucleotide 1091 (in the beginning of ORF245). This search demonstrated that most of the 84-bp region upstream of ORF169, which contains the two inverted repeats, is present in BK5-T. Also, only one of the three regions of ORF245 with amino acid sequence similarity to ORF234 (BK5-T) is similar to ORF234 at the DNA level (Fig. 1C) .
The amino acid sequence similarity search with ORF245 from 31 also identified a putative ATP-binding site (39) near the N terminus of ORF245 (Fig. 3) . Nearly identical sites are found in DNA polymerase accessory proteins that form part of the processive DNA replication complex in yeasts, humans, and bacteriophage T4 (10, 33, 55) . Nucleotide-binding sites are also present in a variety of other energy-requiring proteins including proteases (17) , kinases (20) , and restriction endonucleases (46, 56) .
Reduced sensitivity of 31 to AbiA when the mutant ORF245 from 31A is present in trans. To determine if the mutation identified in 31A-ORF245 is responsible for resistance to AbiA, we tested 31A-ORF245 for complementation during 31 infection in L. lactis bearing AbiA. The mutation in 31B was not tested for complementation, because it does not occur in a coding region. No RNA homologous to ORF245 was detected from pTRK402 (31 EcoRV-SalI fragment) or pTRK403 (31A EcoRV-SalI fragment) (Fig. 4) . Therefore, the promoter for ORF245 is either not on the EcoRV-SalI fragment or is not expressed constitutively at detectable levels. To construct plasmids that would express ORF245, 31-ORF245 and 31A-ORF245 were isolated by PCR with Pfu polymerase and cloned behind a lactococcal promoter (the promoter for the LlaI operon [46] ) in the plasmid pNZ18 (15) . These plasmids were designated pTRK431 (31-ORF245) and pTRK432 (31A-ORF245). RNA homologous to ORF245 was detected from both of these plasmids (Fig. 4) .
Plasmids pTRK431 (31-ORF245) and pTRK432 (31A- ORF245) were each combined with either a high-or a medium-copy-number AbiA plasmid (pTRK376 and pTRK362, respectively), and the resulting transformants were infected with phage 31. Clones containing each AbiA plasmid and pNZ18 were used as controls. The resulting EOPs and plaque morphologies are described in Table 3 . In the strains containing the high-copy-number AbiA plasmid (pTRK376), only a 0.5-log increase in EOP was observed in the presence of 31A-ORF245 compared to 31-ORF245 or pNZ18 (no ORF245). No differences in the plaque morphology of 31 were observed in these experiments.
When the copy number of AbiA was lowered (pTRK362), the presence of 31A-ORF245 in trans resulted in a significant increase in plaque size and clarity of 31 compared to those for the pTRK431-and pNZ18-containing strains ( Table 3 ). The EOP of 31 was also slightly higher, although this was likely due to the higher visibility of these plaques. On strains containing 31-ORF245 or pNZ18, 31 produced very small turbid plaques. These data demonstrate that the mutant ORF245 from 31A can provide 31 with partial protection from AbiA in trans.
Transcriptional analysis of ORF245. To further characterize ORF245, RNA homologous to ORF245 was analyzed to determine (i) when ORF245 is expressed during the phage infection, (ii) if AbiA affects the transcription of ORF245, and (iii) if 31A and 31B differ from 31 in the transcription of ORF245. RNA was isolated from NCK203(pTRKH2) and NCK203(pTRK376 [AbiA]) at 0, 10, 20, 30, 40, and 50 min after infection with 31, 31A, or 31B at a multiplicity of infection of five. Cells sensitive to these phages lyse 55 min after infection under these conditions. Equal amounts of RNA were applied to a nylon membrane with a slot blot apparatus and hybridized to an ORF245-specific probe as described in Materials and Methods. The results indicated that ORF245 is expressed early in the infection cycles of all three phages (Fig. 5) . RNA homologous to ORF245 is most abundant 10 and 20 min after infection, with decreasing amounts at 30, 40, and 50 min. AbiA does not have a significant effect on transcription of this gene from any of the phages. 31A has amounts of ORF245 RNA at 10 and 20 min that are slightly higher than those of 31 or 31B (Fig. 5) . Similar results were obtained when an ORF169-specific probe was used (data not shown), indicating that this region of the 31 genome is transcribed early in the infection cycle.
A 118-bp phage DNA fragment virtually eliminates AbiA activity in trans. While considering complementation experiments with 31A-ORF245 in trans, we discovered that the cloned EcoRV-SalI fragments from either 31 (pTRK402) or 31A (pTRK403) virtually eliminate AbiA activity on 31 when present in NCK203 (pTRK406 [AbiA]) (Table 4) . A control strain containing pTRKH2 and pTRK406 (AbiA) exhibited complete AbiA activity ( Table 4 ), indicating that the cloned phage fragments were responsible for the loss of activity. Neither pTRK402 (31 EcoRV-SalI fragment) nor pTRK403 (31A EcoRV-SalI fragment) had an effect on 31 infection when either was the sole plasmid present (data not shown). Isolation and phenotypic testing of pTRK406 (AbiA) from strains containing pTRK402 or pTRK403 confirmed that the loss of AbiA activity did not result from a mutation in the abiA gene. DNA fragments representing 25 kb of the 31 genome (31.9 kb) were cloned and tested for disruption of AbiA activity in trans. Of these, only the EcoRV-SalI fragment eliminated AbiA activity against 31, indicating that this is not a general phenomenon associated with other regions of the phage genome.
This phenotype was investigated in more detail in 31 because it provided another correlation between AbiA and this region of the 31 genome. Subcloning of HindIII fragments   FIG. 4 . Total RNA (10 g) isolated from NCK203 containing pTRK431, pTRK432, pTRK402, or pTRK403 and hybridized to an ORF245-specific probe. RNA isolated from NCK203 10 min after infection with 31 was included as positive control, and RNA isolated from NCK203 was the negative control.
FIG. 5. Total RNA (8 g) isolated from NCK203(pTRKH2) and NCK203(pTRK376) at 10-min intervals after infection with 31, 31A, and 31B and hybridized to an ORF245-specific probe. within the 31 EcoRV-SalI fragment localized the determinant causing loss of AbiA activity to the EcoRV-HindIII fragment (Fig. 1A) . Bidirectional deletion analysis of the EcoRV-HindIII fragment localized the AbiA-inactivating region to 196 bp (Fig. 6A) .
To identify which sequences were necessary for the reduction in AbiA activity, various fragments within the 187-bp area were amplified by PCR with the primers indicated in Fig. 6B . Fragments were named according to the names of the upstream and downstream primers used in their amplification. Each PCR product was cloned into the EcoRV site of pTRKH2, and the resulting clones were electroporated into NCK203(pTRK406 [AbiA] ). These strains were tested for AbiA activity against 31. The smallest fragment that caused loss of AbiA activity in trans was L2R2. Fragment L2R2 is 118 bp long and consists of the last 12 bp of ORF71, the 84-bp region between ORF71 and ORF169, and the first 22 bp of ORF169. No complete ORF is present within L2R2. Within this fragment are the two sets of inverted repeats upstream of ORF169 (Fig. 3) . Smaller fragments within L2R2 were generated by PCR and tested for their effect on AbiA activity. The fragments generated with primers L2R3 and L3R2 had little or no effect on AbiA function (Table 4) .
Plasmid pTRK426 has the L2R2 fragment (118 bp) (Fig. 6B ) cloned in the same orientation as the lacZ gene in pTRKH2. A clone containing L2R2 in the opposite orientation, pTRK426-reverse, was also tested. AbiA activity is lost when the L2R2 fragment was cloned in either orientation in pTRKH2 (Table  4) . This, along with the fact that no complete ORF exists within the L2R2 fragment, eliminates the possibility of a protein encoded by this DNA causing loss of AbiA activity. No RNA homologous to L2R2 was detected from cells containing pTRK426 or pTRK426-reverse (data not shown). To confirm that RNA containing this region could be detected if it was present, in spite of its likely secondary structure, RNA from NCK203 infected with 31 (20 min after infection) was also hybridized to an L2R2 probe. RNA homologous to L2R2 was easily detected with this positive control (data not shown). Therefore, it is unlikely that an RNA derived from the L2R2 fragment is responsible for loss of AbiA activity caused by pTRK426 or pTRK426-reverse. These data suggest that the loss of AbiA activity is due to the presence of the plasmidborne 118-bp DNA fragment itself.
Since the 31A sequence is identical to 31 throughout the L2R2 fragment, the 31A-L2R2 fragment was not examined. On the other hand, 31B had a mutation within this region (Fig. 3) , so the L2R2 fragment from 31B was isolated by PCR and cloned into pTRKH2. The sequence of the cloned fragment was confirmed. The 31B-L2R2 fragment also caused the loss of AbiA activity that was associated with the wild-type fragment ( Table 4) .
The 31 EcoRV-HindIII fragment does not reduce AbiA activity on phage ul36, sk1, or c2. One possible explanation for the loss of AbiA activity against 31 in the presence of the L2R2 fragment was that AbiA bound to the cloned phage DNA fragment and was titrated from a binding site on the incoming phage genome. To test this hypothesis, the following experiment was performed. Plasmids pTRK406 (AbiA) and pTRK409 (31 EcoRV-HindIII fragment) were combined in L. lactis MG1363, the host for the phages sk1 and c2. Phages sk1 and c2 represent different species which are also sensitive to pTRK406 (AbiA) (data not shown). Phage ul36, which belongs to the same species as 31 (P335), was also tested in the L. lactis NCK203 background. If AbiA binds directly to the L2R2 region, we expected AbiA activity to be reduced against these three phages in the presence of the EcoRV-HindIII fragment from 31. The results indicated that AbiA activity against ul36, sk1, and c2 is not affected by the presence of pTRK409 (31 EcoRV-HindIII fragment) (data not shown). Therefore, AbiA does not appear to bind to L2R2 directly but may require a 31-specific factor for this interaction. DNA fragments representing 88% of the sk1 genome were cloned and combined with pTRK406 (AbiA) in L. lactis MG1363 to test for loss of AbiA activity on phage sk1 (29a). None of the fragments cloned caused loss of AbiA activity. The 12% of the sk1 genome that we were unable to clone intact was in the early region (9) . Given that the L2R2 fragment is in the early region of the 31 genome, it is possible that a similar fragment that could not be cloned exists in sk1. Alternatively, the loss of AbiA activity associated with a phage DNA fragment may be specific to 31.
DISCUSSION
An AbiA-insensitive phage 31 mutant (31A) was used to identify a region of the 31 genome that is involved in the sensitivity of this phage to the AbiA abortive phage infection mechanism. The mutation in the AbiA-insensitive phage was localized by analyzing 31::31A DNA hybrids for heteroduplexes with a commercial gel matrix. The mutation identified was a G-to-T transversion and occurred in an ORF designated ORF245. The mutant 31A-ORF245 partially complemented 31 infection, allowing increased growth of 31 in the presence of AbiA. This suggests that the mutation in 31A-ORF245 is responsible for the AbiA insensitivity phenotype observed in this phage and that the wild-type ORF245 is necessary for AbiA to inhibit the phage. Bidnenko et al. (5) also saw partial complementation of the wild-type phage (bIL66) in the presence of AbiD1 with a DNA fragment from an AbiD1-resistant phage (bIL66M1).
RNA analysis indicated that ORF245 is transcribed early during 31 infection. Hill et al. (24) reported that 31 DNA replication is inhibited in cells containing AbiA. Thus, AbiA halts phage proliferation early in the infection cycle. The involvement of ORF245, an early gene, in the sensitivity of 31 to AbiA is consistent with these findings. The putative ATPbinding site identified in ORF245 is also interesting in this context, because a virtually identical site is found in several DNA polymerase accessory proteins, including gp44 from the E. coli phage T4 (55) . Analysis of ORF245 RNA also revealed that AbiA does not significantly affect the level of transcription of this gene from 31, 31A, or 31B.
Immediately upstream of ORF245 lies another ORF, ORF169, which is preceded by ORF71. Between ORF71 and ORF169 is an 84-bp untranslated region containing two sets of inverted repeats. It is within one of the inverted repeats that the AbiA-insensitive phage 31B has a G-to-A mutation. The specific role of this mutation in AbiA insensitivity was not uncovered in this study.
A relationship between AbiA and the region upstream of ORF169 was discovered. The 31 EcoRV-SalI fragment containing this region was found to virtually eliminate AbiA activity on 31 in trans. This was the only fragment to have this property over 78% of the 31 genome tested. The determinant causing this phenotype was localized to a 118-bp DNA fragment (designated L2R2) containing two sets of inverted repeats located upstream of ORF169. No RNA homologous to L2R2 was detected in cells containing pTRK426 (31 L2R2 fragment); therefore, the loss of AbiA activity caused by this fragment likely occurs directly or indirectly at the DNA level. It is intriguing that this sequence protects 31 against AbiA when on a high-copy-number plasmid but not when on the phage genome. Considering this, we may speculate that the plasmid-borne L2R2 fragment provides a false target for AbiA, leaving the target on the phage genome unaffected. Alternatively, the plasmid-borne L2R2 fragment may titrate away a phage regulatory factor, resulting in an excess of the AbiA phage target. Further experimentation is required to completely characterize the relationship between AbiA and L2R2.
The 1,732 bp of DNA sequenced from 31 and the translated proteins have extensive similarities with the genome of the temperate lactococcal phage BK5-T. The effect of AbiA on BK5-T has not been reported; therefore, comparisons in relation to AbiA sensitivity are not possible. Another part of the 31 genome has sequence similarity to the temperate phage, LC3 (45) . The sequence similarities now identified between 31 and the temperate phages LC3 and BK5-T establish a direct linkage between a virulent lactococcal phage and temperate phages in lactococci.
Although ORF169 and ORF245 from phage 31 are conserved in a temperate lactococcal phage, they are not present in the lytic prolate phage c2 genome, which was recently sequenced (34) . AbiA retards phage c2, but not as effectively as it retards small isometric-headed phages. This observation suggests that AbiA could function differently against different phage species.
Phages insensitive to a particular Abi mechanism have proven to be useful tools in identifying regions of the phage involved in sensitivity to the mechanism (reference 5 and this study). Given the complexity of the phage-Abi interaction in the AbiD1 (5) and the AbiA systems, a complete understanding of the molecular mechanisms behind abortive phage infection in lactococci will require thorough study of the Abi gene and protein, as well as extensive characterization of the phage genes and gene products involved. Information obtained from these studies will contribute significantly to the design of phage-resistant starter cultures in the future.
